Days of Therapy and Antimicrobial Days: Similarities and Differences between Consumption Metrics

Infection Control and Hospital Epidemiology

Volumn 37, Issue 8, 2016, Pages 971-973

  Rhodes, Nathaniel J ^a   Wagner, Jamie L ^b   Gilbert, Elise M ^c   Crew, Page E ^a   Davis, Susan L ^d   Scheetz, Marc H ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c CHICAGO STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; ERTAPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC THERAPY; ARTICLE; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; QUALITY CONTROL; TREATMENT DURATION; BENCHMARKING; CLINICAL PRACTICE; COMPARATIVE STUDY; STANDARDS; TIME FACTOR;

ANTI-BACTERIAL AGENTS; BENCHMARKING; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; TIME FACTORS;

EID: 84979937156     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2016.109     Document Type: Article

References (6)

1. Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR 2014;63:194-200.
2. National Healthcare Safety Network (NHSN) Antimicrobial Use and Resistance (AUR) Module. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/ pscManual/11pscAURcurrent.pdf. Published 2016. Accessed April 11, 2016.
3. Cohen AL, Calfee D, Fridkin SK, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect Control Hosp Epidemiol 2008;29:901-913.
4. McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother 2013;57:5131-5133.
5. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664-670.
6. Monnet DL, Lopez-Lozano JM, Campillos P, Burgos A, Yague A, Gonzalo N. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect 2001;7:29-36.